nalidixic acid has been researched along with pefloxacin in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 48 (70.59) | 18.7374 |
1990's | 11 (16.18) | 18.2507 |
2000's | 6 (8.82) | 29.6817 |
2010's | 3 (4.41) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
Irikura, T; Itoh, A; Koga, H; Murayama, S; Suzue, S | 1 |
Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W | 1 |
Courvalin, P; Galimand, M; Périchon, B | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Bremont, S; Charavay, F; Courvalin, P; Goarant, C; Le Hello, S; O'Connor, O; Page, S; Vernel-Pauillac, F | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Rahal, K | 1 |
Chelfi, A; Liassine, N; Rahal, K | 1 |
Carret, G; Flandrois, JP; Lobry, JR | 1 |
Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
Deforges, L; Duval, J; Leclercq, R; Soussy, CJ | 1 |
Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
Geitz, JN; Lerk, CF; Tarko-Smit, NJ; Van Saene, HK; Van Saene, JJ | 1 |
Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC | 1 |
Avesani, V; Delmee, M | 1 |
Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
Høiby, N | 1 |
Allocati, N; Oliva, B; Renzini, G; Scazzocchio, F; Schippa, S; Selan, L | 1 |
Cellini, L; Oliva, B; Renzini, G; Scazzocchio, F; Schippa, S; Selan, L | 1 |
Clarke, AM; Zemcov, SJ | 1 |
Campbell, ME; Clarke, AM; Zemcov, SJ | 1 |
Borsa, F; Humbert, G | 1 |
Gordin, FM; Hackbarth, CJ; Sande, MA; Scott, KG | 1 |
Montay, G; Tassel, JP | 1 |
Pilliot, J; Ronco, E | 1 |
Dabernat, H; Delmas, C; Lareng, MB | 1 |
Daguet, GL; Delisle-Mizon, F; Lesage, D; Vergez, P | 1 |
Bergogne-Berezin, E; Joly-Guillou, ML | 1 |
Bryskier, A; Devos, J; Dubreuil, L; Romond, C | 1 |
Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L | 1 |
Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F | 1 |
King, A; Phillips, I | 1 |
Wolff, M | 1 |
Modaï, J | 1 |
Chambers, HF; Hackbarth, CJ; Sande, MA; Scott, KG; Sullam, PM; Täuber, MG | 1 |
Bryskier, A; Husson, MO; Izard, D; Leclerc, H | 1 |
Bryskier, A; Chantot, JF | 1 |
Bryskier, A; Croize, J; Le Noc, P; Robert, J | 1 |
Blain, Y; Le Hir, A; Montay, G; Roquet, F | 1 |
Bebear, C; Cantet, P; Quentin, C; Renaudin, H | 1 |
Benvenisty, AI; Fox, CL; Modak, S; Nowygrod, R; Reemtsma, K; Voorhees, AB; White, JV | 1 |
Hoogkamp-Korstanje, JA | 1 |
Husson, MO; Izard, D; Leclerc, H | 1 |
Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
Carbon, C; Contrepois, A; Daldoss, C; Garaud, JJ; Kecir, M; Pangon, B; Sarrazin, C; Vallois, JM | 1 |
Fox, CL; Fox, P; Friedlaender, J; Modak, S; Stanford, J | 1 |
Goueffon, Y; Montay, G; Roquet, F | 1 |
Bonhommet, M; David, JC; Rusquet, R | 1 |
Benard, Y; Langeard, M; Morel, C; Vergnaud, M | 1 |
Meier-Ewert, H; Millott, G; Weil, G | 1 |
Barre, J; Houin, G; Tillement, JP | 1 |
Daldoss, C; Nkam, M; Regnier, B; Vachon, F; Wolff, M | 1 |
Durosoir, JL; Thabaut, A | 1 |
Kasatkina, IV; Lozovoĭ, NV; Pasiukov, VV; Shcherbaniuk, AI | 1 |
Domarle, O; Hayem, G; Pocidalo, JJ; Thuong-Guyot, M | 1 |
Kasatkina, IV; Makarovskaia, LN; Padeĭskaia, EN; Sherbaniuk, AI | 1 |
Carret, G; Flandrois, JP; Guerillot, F | 1 |
Auckenthaler, R; Peyret, M; Rohner, P | 1 |
Adolphe, M; Bernard-Beaubois, K; Hayem, G; Hecquet, C; Rat, P | 1 |
Fernández, F; Martínez-Martínez, L; Perea, EJ | 1 |
Debray, M; Dutot, M; Martin, C; Pouzaud, F; Rat, P; Warnet, JM | 1 |
Åhman, J; Kahlmeter, G; Matuschek, E; Petersen, A; Sjölund-Karlsson, M; Skov, R; Stegger, M; Torpdahl, M | 1 |
68 other study(ies) available for nalidixic acid and pefloxacin
Article | Year |
---|---|
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids.
Topics: Anti-Bacterial Agents; Bacteria; Quinolines; Structure-Activity Relationship | 1980 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae.
Topics: Amino Acid Substitution; Base Sequence; DNA Gyrase; DNA Mutational Analysis; DNA Primers; DNA Probes; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Humans; Nucleic Acid Denaturation; Point Mutation; Polymerase Chain Reaction; Streptococcus pneumoniae; Thermodynamics | 2008 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Species Specificity | 1992 |
[Resistance to new quinolones among the enterobacteria].
Topics: Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Nalidixic Acid; Ofloxacin; Pefloxacin; Recurrence; Urinary Tract Infections | 1992 |
Biphasic kinetics of bacterial killing by quinolones.
Topics: Colony Count, Microbial; Escherichia coli; Humans; Infant, Newborn; Models, Theoretical; Nalidixic Acid; Ofloxacin; Pefloxacin | 1991 |
[Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype; Staphylococcus aureus | 1990 |
[In vitro antibacterial activity of a new fluoroquinolone, fleroxacin as a function of the sensitivity or resistance to nalidixic acid and to pefloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fleroxacin; Microbial Sensitivity Tests; Nalidixic Acid; Pefloxacin | 1989 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Quinolones and colonization resistance in human volunteers.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Digestive System; Feces; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines | 1986 |
In-vitro activity of newer quinolones against aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Calcium; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Magnesium Sulfate; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas; Quinolines; Sulfates; Zinc; Zinc Sulfate | 1986 |
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
Plasmid "curing" by some recently synthetized 4-quinolone compounds.
Topics: Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Pefloxacin; Plasmids | 1988 |
Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; R Factors | 1988 |
In vitro activity of the new 4-quinolone compound Ro 23-6240.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Enoxacin; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin | 1985 |
[Treatment of urinary tract infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; Female; Humans; Lactams; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Prostatitis; Urinary Tract Infections | 1985 |
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Ciprofloxacin; Guinea Pigs; Half-Life; Microbial Sensitivity Tests; Nalidixic Acid; Neutropenia; Pefloxacin; Pneumonia; Pseudomonas Infections; Quinolines; Time Factors | 1985 |
Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Humans; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Prostate | 1985 |
[Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains].
Topics: Coagulase; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Penicillin Resistance; Staphylococcus; Staphylococcus aureus | 1985 |
[Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria meningitidis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Streptococcus pneumoniae | 1985 |
[Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Topics: Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Pseudomonas; Pseudomonas aeruginosa; Quinolines | 1985 |
[Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Topics: Acinetobacter; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1985 |
[Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
Topics: Bacteria, Anaerobic; Bacteroides; Clostridium; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1985 |
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections | 1988 |
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen | 1987 |
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines | 1986 |
[Therapeutic contribution of the new quinolones].
Topics: Anti-Infective Agents; Bacterial Infections; Biotransformation; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Therapy, Combination; Humans; Kinetics; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
[Therapeutic contribution of recently marketed antibiotics].
Topics: Anti-Bacterial Agents; Cephalosporins; Fosfomycin; Humans; Nalidixic Acid; Netilmicin; Pefloxacin | 1985 |
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Endocarditis, Bacterial; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Pefloxacin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Vancomycin | 1985 |
Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid | 1985 |
Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Blood Proteins; Drug Resistance, Microbial; Male; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Protein Binding | 1985 |
[Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Topics: Acinetobacter; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas aeruginosa | 1985 |
High-performance liquid chromatography of pefloxacin and its main active metabolites in biological fluids.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Humans; Nalidixic Acid; Norfloxacin; Pefloxacin; Time Factors | 1983 |
[Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Topics: 4-Quinolones; Anti-Bacterial Agents; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Ureaplasma | 1983 |
Simple methods for direct antibiotic protection of synthetic vascular grafts.
Topics: Animals; Antisepsis; Asepsis; Blood Coagulation; Blood Vessel Prosthesis; Cefamandole; Cefazolin; Dogs; Microscopy, Electron, Scanning; Nafcillin; Nalidixic Acid; Pefloxacin; Polyethylene Terephthalates; Protein Binding; Silver | 1984 |
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Respiratory Tract Infections; Trimethoprim; Urinary Tract Infections | 1984 |
In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
Topics: 4-Quinolones; Anti-Infective Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines; Quinolones; Species Specificity | 1984 |
In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin | 1984 |
Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
Topics: Animals; Anti-Infective Agents; Diffusion; Endocarditis, Bacterial; Escherichia coli Infections; Furosemide; Male; Nalidixic Acid; Pefloxacin; Protein Binding; Rabbits | 1984 |
Control of burn wound infections by pefloxacin and its silver derivative.
Topics: Administration, Topical; Animals; Body Weight; Burns; Female; Mice; Nalidixic Acid; Pefloxacin; Pseudomonas Infections; Rats; Silver; Sulfadiazine; Time Factors; Tissue Distribution | 1984 |
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.
Topics: Adult; Animals; Bile; Biotransformation; Chromatography, High Pressure Liquid; Dogs; Female; Humans; Intestinal Absorption; Kinetics; Macaca fascicularis; Male; Mice; Nalidixic Acid; Pefloxacin; Protein Binding; Rats; Rats, Inbred Strains; Species Specificity; Spectrometry, Fluorescence; Tissue Distribution | 1984 |
Quinolone antibiotics inhibit eucaryotic DNA polymerase alpha and beta, terminal deoxynucleotidyl transferase but not DNA ligase.
Topics: Animals; Anti-Infective Agents, Urinary; Chickens; DNA Ligases; DNA Nucleotidylexotransferase; DNA Nucleotidyltransferases; DNA Polymerase I; DNA Polymerase II; Electrophoresis, Polyacrylamide Gel; Kinetics; Nalidixic Acid; Nucleic Acid Synthesis Inhibitors; Oxolinic Acid; Pefloxacin; Polynucleotide Ligases; Quinolines; Thymus Gland | 1984 |
[Pefloxacine: diffusion into bronchial mucus].
Topics: Anti-Infective Agents; Biological Assay; Bronchi; Humans; Mucus; Nalidixic Acid; Pefloxacin | 1984 |
In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1984 |
Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.
Topics: Administration, Oral; Anti-Infective Agents; Dose-Response Relationship, Drug; Humans; Infusions, Parenteral; Kinetics; Nalidixic Acid; Pefloxacin | 1984 |
Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Child; Diffusion; Female; Humans; Male; Meningitis; Middle Aged; Nalidixic Acid; Pefloxacin | 1984 |
[Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
Topics: Anti-Infective Agents, Urinary; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Nalidixic Acid; Pefloxacin; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Quinolizines | 1982 |
[Effectiveness of new quinolones in experimental aerogenic plague infection of albino mice].
Topics: 4-Quinolones; Administration, Inhalation; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Lethal Dose 50; Mice; Nalidixic Acid; Pefloxacin; Plague; Quinolones | 1994 |
Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production.
Topics: Animals; Anti-Infective Agents; Cartilage; Cell Survival; Cells, Cultured; Ciprofloxacin; Flow Cytometry; Free Radicals; Macrophages, Alveolar; Nalidixic Acid; Ofloxacin; Pefloxacin; Rabbits | 1994 |
[Effectiveness of the new quinolones, ciprofloxacin and pefloxacin in experimental plague].
Topics: Animals; Ciprofloxacin; Evaluation Studies as Topic; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Pefloxacin; Plague | 1993 |
Mathematical model for comparison of time-killing curves.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cell Cycle; Cephalothin; Escherichia coli; Kinetics; Mathematical Computing; Microbial Sensitivity Tests; Models, Biological; Nalidixic Acid; Ofloxacin; Pefloxacin; Time Factors | 1993 |
Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Topics: Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbiological Techniques; Nalidixic Acid; Ofloxacin; Pefloxacin; Staphylococcus; Virginiamycin | 1993 |
In vitro study of cytotoxicity of quinolones on rabbit tenocytes.
Topics: Animals; Anti-Infective Agents; Cell Survival; Cells, Cultured; Collagen; Decorin; Extracellular Matrix Proteins; Mitochondria; Nalidixic Acid; Norfloxacin; Pefloxacin; Proteoglycans; Rabbits; Succinate Dehydrogenase; Tendons | 1998 |
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gentamicins; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pefloxacin; Tetracycline | 1999 |
Age-dependent effects on redox status, oxidative stress, mitochondrial activity and toxicity induced by fluoroquinolones on primary cultures of rabbit tendon cells.
Topics: Achilles Tendon; Age Factors; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Fluoroquinolones; Glutathione; Mitochondria; Nalidixic Acid; Ofloxacin; Oxidation-Reduction; Oxidative Stress; Pefloxacin; Rabbits; Reactive Oxygen Species | 2006 |
Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacteremia; Base Sequence; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Nalidixic Acid; Ofloxacin; Pefloxacin; Salmonella enterica; Salmonella Infections; Sequence Analysis, DNA | 2015 |